OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurochemistry is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain	150
Microglial phagocytosis of neurons in neurodegeneration, and its regulation	117
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease	90
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease	88
Chrono‐nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns	86
Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases	80
Role of sphingolipid metabolism in neurodegeneration	64
Exosomes in Parkinson disease	61
Microbiota‐gut‐brain axis as a regulator of reward processes	59
STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies	55
Presynaptic dysfunction in neurodevelopmental disorders: Insights from the synaptic vesicle life cycle	52
Amyloid‐β oligomers in cellular models of Alzheimer’s disease	49
Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer’s disease	48
Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies	47
Protective actions of exercise‐related FNDC5/Irisin in memory and Alzheimer’s disease	45
Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer	44
Disorders of synaptic vesicle fusion machinery	43
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance	42
Pannexin‐1 in the CNS: Emerging concepts in health and disease	42
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD	42
The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders	41
Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease	41
Direct dopamine terminal regulation by local striatal microcircuitry	40
Viral infection and smell loss: The case of COVID‐19	40
Emerging role of PARP‐1 and PARthanatos in ischemic stroke	39

Acute pharmacological inhibition of matrix metalloproteinase‐9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice	39
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease	39
MicroRNA‐22‐3p alleviates spinal cord ischemia/reperfusion injury by modulating M2 macrophage polarization via IRF5	38
Ferroptosis: An emerging therapeutic target in stroke	37
Receptor for advanced glycation end products up‐regulation in cerebral endothelial cells mediates cerebrovascular‐related amyloid β accumulation after Porphyromonas gingivalis infection	37
24S‐hydroxycholesterol: Cellular effects and variations in brain diseases	37
The neurodevelopmental spectrum of synaptic vesicle cycling disorders	36
Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex	36
Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1‐dependent mitochondrial fission	36
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species	35
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy	35